Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05547321 |
Title | Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors. |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Oncomatryx Biopharma S.L. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Beth Israel Deaconess Medical Center | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
ICO L'Hospitalet | RECRUITING | L'Hospitalet de Llobregat | Barcelona | Spain | Details | |
Hospital Universitario de Donostia | RECRUITING | San Sebastián | Guipúzcoa | Spain | Details | |
Clínica Universitaria de Navarra | RECRUITING | Pamplona | Navarra | Spain | Details | |
Hospital Universitari Vall d'Hebron | NOT_YET_RECRUITING | Barcelona | Spain | Details | ||
Hospital 12 Octubre | RECRUITING | Madrid | Spain | Details | ||
Hospital MD Anderson | RECRUITING | Madrid | Spain | Details | ||
Onkologikoa | RECRUITING | San Sebastián | Spain | Details |